Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome

被引：1
|
作者：
Proietti, Ilaria [1 ]
Tolino, Ersilia [1 ]
Bernardini, Nicoletta [1 ]
Di Fraia, Marco [1 ]
Skroza, Nevena [1 ]
Potenza, Concetta [1 ]
机构：
[1] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Polo Pontino, Corso Repubbl 79, I-04100 Latina, LT, Italy
来源：
DERMATOLOGY PRACTICAL & CONCEPTUAL | 2023年 / 13卷 / 03期
关键词：
D O I：
10.5826/dpc.1303a178
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme
    Challapalli, A.
    Watkins, S.
    Cogill, G.
    Stewart, G.
    Ellis, S.
    Sykes, A.
    Nobes, J.
    Yip, K.
    Barthakur, U.
    Board, R.
    Gadve, A.
    O'Toole, L.
    Kent, C.
    Mackenzie, J.
    Papa, S.
    Fusi, A.
    Fife, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : E590 - E592
  • [22] Systemic drug therapy with cemiplimab for cutaneous squamous cell carcinoma (SCC)
    Kupf, S.
    Schultz, E.
    Debus, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 74 - 75
  • [23] Cemiplimab as a neoadjuvant therapy approach for advanced cutaneous squamous cell carcinoma
    Korsing, S.
    Eigentler, T.
    Ulrich, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 39 - 39
  • [24] Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma
    Croce, E.
    Boutros, A.
    Tanda, E. T.
    Cecchi, F.
    Arecco, L.
    Genova, C.
    Baldelli, I.
    Lambertini, M.
    Raposio, E.
    Del Mastro, L.
    Spagnolo, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S684 - S684
  • [25] Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
    Hanna, Glenn J.
    Dharanesswaran, Harita
    Giobbie-Hurder, Anita
    Harran, John J.
    Liao, Zixi
    Pai, Lori
    Tchekmedyian, Vatche
    Ruiz, Emily S.
    Waldman, Abigail H.
    Schmults, Chrysalyne D.
    Riella, Leonardo V.
    Lizotte, Patrick
    Paweletz, Cloud P.
    Chandraker, Anil K.
    Murakami, Naoka
    Silk, Ann W.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (09) : 1021 - 1030
  • [26] Cemiplimab-rwlc Approved in Advanced Cutaneous Squamous Cell Carcinoma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (11) : 707 - 707
  • [27] Therapy with Cemiplimab for locally advanced cutaneous Squamous Cell Carcinoma (cSCC)
    Reschke, R.
    Simon, J. C.
    Kage, P.
    Ziemer, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 41 - 42
  • [28] Cemiplimab for advanced cutaneous squamous cell carcinoma: Real life experience
    Hober, C.
    Fredeau, L.
    Ledard, A. Pham
    Boubaya, M.
    Herms, F.
    Aubin, F.
    Benetton, N.
    Dinulescu, M.
    Jannic, A.
    Cesaire, L.
    Meyer, N.
    Modeste, A. B. Duval
    Archier, E.
    Lesage, C.
    Kramkimel, N.
    Arnault, J. P.
    Grange, F.
    Dalac, S.
    Mortier, L.
    Maubec, E.
    ANNALS OF ONCOLOGY, 2020, 31 : S737 - S737
  • [29] Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma
    Boutros, Andrea
    Croce, Elena
    Tanda, Enrica Teresa
    Cecchi, Federica
    Arecco, Luca
    Genova, Carlo
    Baldelli, Ilaria
    Lambertini, Matteo
    Raposio, Edoardo
    Del Mastro, Lucia
    Spagnolo, Francesco
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (02)
  • [30] Safety of cemiplimab for advanced cutaneous squamous cell carcinoma in a patient with p-ANCA-associated vasculitis
    Pham, James P.
    Sivasubramaniam, Vanathi
    Gallagher, Richard
    Forstner, Dion
    Wong, Muh
    Liu, Jia
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : E363 - E365
12345